Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-08

FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril), a generic ACE inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAPTOPRIL (Captopril)

Snippet

SUPPL AP for CAPTOPRIL (CAPTOPRIL)